Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862338
Status:
COMPLETED
Last Update Posted:
2023-01-26
First Post:
2021-04-21
Brief Title:
Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide NMN 400mgDay in Healthy Adults
Sponsor:
Seneque SA
Organization:
Seneque SA
Study Overview
Official Title:
Pharmacodynamics and Tolerance Study of Nicotinamide Mononucleotide NMN Supplementation at 400 mgDay
Status:
COMPLETED
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the physiological andor biological actions of nicotinamide mononucleotide NMN-C in healthy adults receiving a repeated-dose over the course of 28 days by studying the tolerance and pharmacodynamics of this product
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None